ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support

Li Fu,Shaohua Shi,Jiacai Yi,Ningning Wang,Yuanhang He,Zhenxing Wu,Jinfu Peng,Youchao Deng,Wenxuan Wang,Chengkun Wu,Aiping Lyu,Xiangxiang Zeng,Wentao Zhao,Tingjun Hou,Dongsheng Cao

DOI: https://doi.org/10.1093/nar/gkae236

IF: 14.9

2024-04-05

Nucleic Acids Research

Abstract:ADMETlab 3.0 is the second updated version of the web server that provides a comprehensive and efficient platform for evaluating ADMET-related parameters as well as physicochemical properties and medicinal chemistry characteristics involved in the drug discovery process. This new release addresses the limitations of the previous version and offers broader coverage, improved performance, API functionality, and decision support. For supporting data and endpoints, this version includes 119 features, an increase of 31 compared to the previous version. The updated number of entries is 1.5 times larger than the previous version with over 400 000 entries. ADMETlab 3.0 incorporates a multi-task DMPNN architecture coupled with molecular descriptors, a method that not only guaranteed calculation speed for each endpoint simultaneously, but also achieved a superior performance in terms of accuracy and robustness. In addition, an API has been introduced to meet the growing demand for programmatic access to large amounts of data in ADMETlab 3.0. Moreover, this version includes uncertainty estimates in the prediction results, aiding in the confident selection of candidate compounds for further studies and experiments. ADMETlab 3.0 is publicly for access without the need for registration at: https://admetlab3.scbdd.com.

biochemistry & molecular biology

What problem does this paper attempt to address?

The paper aims to address the issue of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) property prediction in the drug development process. Specifically, the paper introduces ADMETlab 3.0, an updated and more comprehensive online ADMET prediction platform that addresses the limitations of the previous version by incorporating broader data coverage, improved performance, API functionality, and decision support.

The main improvements include:
1. **Broader data coverage**: 31 new prediction endpoints have been added, totaling 119 features. The number of data entries has increased by 1.5 times compared to the previous version, reaching over 400,000 entries.
2. **Enhanced model performance**: The use of a multi-task DMPNN architecture combined with molecular descriptors has significantly improved the accuracy and robustness of the prediction models.
3. **API functionality**: API functionality has been introduced to meet users' needs for programmatic access to large amounts of data.
4. **Uncertainty estimation**: Uncertainty estimation is provided in the prediction results, helping researchers more confidently select candidate compounds for further study and experimentation.

Overall, ADMETlab 3.0 aims to provide drug developers and chemists with a more comprehensive, reliable, and accurate service to accelerate the drug development process.